BACKGROUND In the United States, the burden of human papillomavirus (HPV)‐associated
cancers varies by racial/ethnic group. HPV vaccination may provide opportunities for primary …

Objectives Human papillomavirus (HPV) is a common virus that currently infects nearly 80
million people in the United States (US) and can lead to cancer. HPV vaccination provides …

Human papillomavirus (HPV) causes roughly 1.6% of the plus 1.6 million cases of cancer
that are diagnosed in the United States each year. Despite the proven safety and efficacy of …

Studies disagree about whether racial and ethnic groups have lower or higher human
papillomavirus (HPV) vaccination uptake, an important issue given large disparities in some …

Human papillomavirus (HPV) causes cervical as well as other cancers. Racial and ethnic
disparities in cervical cancer incidence and mortality in the United States are well …

Background We assessed disparities in HPV vaccination coverage by sociodemographic
characteristics in the United States. Methods Using 2017-March 2020 National Health and …

Postmarket surveillance of the incidence of human papillomavirus (HPV)–related cancers is
essential to monitor the effectiveness of HPV vaccines. We directly compared HPV-related …

Background Human papillomavirus (HPV) is associated with poor health outcomes,
including cervical cancer. Racial/ethnic minority populations experience poor health …

Importance Nearly 45 000 human papillomavirus (HPV)-associated cancers are diagnosed
annually in the US. The HPV vaccine has been approved since 2006, but information on the …

Research has demonstrated that the human papillomavirus (HPV) vaccine is a safe and
effective way to decrease HPV-related cervical cancers; however, the vaccination rate in the …